Photo from wikipedia
The goal of our study was to find predictors for the development of secondary myelodysplastic syndrome or acute myelogenous leukemia (s‐MDS/AML) in patients with relapsed or refractory lymphoma who received… Click to show full abstract
The goal of our study was to find predictors for the development of secondary myelodysplastic syndrome or acute myelogenous leukemia (s‐MDS/AML) in patients with relapsed or refractory lymphoma who received high‐dose chemotherapy and autologous stem cell transplantation (ASCT).
Keywords:
development secondary;
acute myelogenous;
myelogenous leukemia;
myelodysplastic syndrome;
syndrome acute;
secondary myelodysplastic
Journal Title: Transfusion
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Transfusion
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!